Laden…
Midazolam is a short-acting benzodiazepine with sedative, anxiolytic, and anticonvulsant properties. It acts by enhancing GABAergic inhibition in the central nervous system. Due to its pharmacological profile, it is frequently used in anesthesia and for the treatment of anxiety disorders. The substance has a moderate risk regarding dependence and side effects.
Receptor Targets
Mechanism of Action
Designations
IUPAC: Midazepam
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Receptor Profile
Der GABA-A-Rezeptor ist ein ligandengesteuerter Chloridkanal und der wichtigste inhibitorische Rezeptor im zentralen Nervensystem. Er besitzt multiple allosterische Bindungsstellen für verschiedene Substanzklassen.
Synapedia Evidence
Midazolam acts as an agonist at the GABA_A receptors, leading to increased inhibition of neuronal activity. This results in sedative, anxiolytic, and muscle-relaxing effects.
Known Effects
Individual effects may vary significantly. These are pharmacologically documented effects.
Total duration 2-6 hours
Peak
30-60 minutes (oral), 5-10 minutes (iv)
Onset
1-5 minutes (iv), 15-30 minutes (oral)
Total duration
2-6 hours
After effects
1-2 hours
Start low. Individual sensitivity varies.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Summary
Mögliche Abhängigkeit, Sedierung und Atemdepression bei Überdosierung.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.